78229836 - EPTEST

Information

• Trademark
• 78229836

• Source

• Serial Number

  78229836

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  March 25, 2003
  21 years ago

• Transaction Date

  February 02, 2011
  14 years ago

• Status Date

  March 17, 2004
  20 years ago

• Location Date

  March 29, 2004
  20 years ago

• Status Code

  602

• Current Location

  FILE REPOSITORY (FRANCONIA)

  Employee Name

  HAYES, GINA CLARK

• Attorney Docket Number

  0148/331

  Attorney Name

  J. Scott Evans

  Law Office Assigned Location Code

  M30

• Owners

  • Mindset Biopharmaceuticals (USA) Inc.

Case File Statements

• GS0051: Pharmaceutical preparations; antibody preparations; chemical preparations for use in performing polymerase chain reactions (PCR); monoclonal antibodies; chemical preparations for determination of the reaction of an individual's human leucocyte antigen (HLA) haplotype to antigens; chemical preparations for determination of the reaction of an individual's human leucocyte antigen (HLA) haplotype to vaccines; diagnostic preparations and reagents for sale in kit form; biological preparations; biological cultures; cell cultures; cell lines; chemical preparations; cultures of micro organisms; diagnostic preparations; enzymes; genes; DNA; RNA; peptides; polypeptides; proteins; recombinant antibodies; vaccines; including all of the above aforesaid goods for the treatment of amyloidosis, Alzheimer's Disease, Down Syndrome and Mild Cognitive Impairment (MCI); Pharmaceutical preparations; antibody preparations; chemical preparations for use in performing polymerase chain reactions (PCR); monoclonal antibodies; chemical preparations for determination of the reaction of an individual's human leucocyte antigen (HLA) haplotype to antigens; chemical preparations for determination of the reaction of an individual's human leucocyte antigen (HLA) haplotype to vaccines; diagnostic preparations and reagents for sale in kit form; biological preparations; biological cultures; cell cultures; cell lines; chemical preparations; cultures of micro organisms; diagnostic preparations; enzymes; genes; DNA; RNA; peptides; polypeptides; proteins; recombinant antibodies; vaccines; including all of the above aforesaid goods for the treatment of amyloidosis, Alzheimer's Disease, Down Syndrome and Mild Cognitive Impairment (MCI)
• GS0101: Diagnostic test kits; diagnostic test kits for use in polymerase chain reactions (PCR) ; diagnostic test kits and apparatus for determination of an individual's HLA haplotype reaction with vaccines; all the aforesaid for determination of an individual's HLA haplotype reaction with vaccines against Alzheimer's Disease, MCI, amyloidosis and Down Syndrome.; Diagnostic test kits; diagnostic test kits for use in polymerase chain reactions (PCR) ; diagnostic test kits and apparatus for determination of an individual's HLA haplotype reaction with vaccines; all the aforesaid for determination of an individual's HLA haplotype reaction with vaccines against Alzheimer's Disease, MCI, amyloidosis and Down Syndrome.
• GS0421: Scientific, medical and industrial research; vaccine screening; biochemical analysis, biochemical research; diagnosis of predisposition to Alzheimer's Disease, Mild Cognitive Impairment (MCI); amyloidosis and Down Syndrome; disease management; drug design; healthcare; prophylaxis and treatment of medical disorders; prophylaxis, vaccination, vaccine screening, and treatment of Alzheimer's Disease, Down Syndrome, Mild Cognitive Impairment (MCI) and amyloidosis.; Scientific, medical and industrial research; vaccine screening; biochemical analysis, biochemical research; diagnosis of predisposition to Alzheimer's Disease, Mild Cognitive Impairment (MCI); amyloidosis and Down Syndrome; disease management; drug design; healthcare; prophylaxis and treatment of medical disorders; prophylaxis, vaccination, vaccine screening, and treatment of Alzheimer's Disease, Down Syndrome, Mild Cognitive Impairment (MCI) and amyloidosis.
• PM0001: EPT TEST

Case File Event Statements

• 3/17/2004 - 20 years ago

  5 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2

• 8/27/2003 - 21 years ago

  4 - NON-FINAL ACTION MAILED Type: CNRT

• 8/21/2003 - 21 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 7/21/2003 - 21 years ago

  2 - CASE FILE IN TICRS Type: CFIT

• 6/30/2003 - 21 years ago

  1 - PAPER RECEIVED Type: MAIL